1. CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target
- Author
-
James W. Marsh, Peter Timms, Wilhelmina M. Huston, Vanissa A. Ong, William B. Lott, and Joel D. A. Tyndall
- Subjects
Models, Molecular ,0301 basic medicine ,Microbiology (medical) ,DegP ,Virulence Factors ,medicine.drug_class ,Antibiotics ,060109 Proteomics and Intermolecular Interactions (excl. Medical Proteomics) ,Organophosphonates ,Virulence ,Chlamydia trachomatis ,Biology ,medicine.disease_cause ,Models, Biological ,Microbiology ,Treatment failure ,060501 Bacteriology ,Fight-or-flight response ,03 medical and health sciences ,medicine ,Humans ,Protease Inhibitors ,Protease inhibitor (pharmacology) ,060100 BIOCHEMISTRY AND CELL BIOLOGY ,060108 Protein Trafficking ,Chlamydia ,Serine Endopeptidases ,protease ,060500 MICROBIOLOGY ,Dipeptides ,Chlamydia Infections ,medicine.disease ,intracellular ,Anti-Bacterial Agents ,HtrA ,virulence ,030104 developmental biology ,Drug development ,060112 Structural Biology (incl. Macromolecular Modelling) ,Bacterial Outer Membrane Proteins - Abstract
© 2017 Future Medicine Ltd. Chlamydia trachomatis is the most prevalent sexually transmitted bacterial infection worldwide and the leading cause of preventable blindness. Reports have emerged of treatment failure, suggesting a need to develop new antibiotics to battle Chlamydia infection. One possible candidate for a new treatment is the protease inhibitor JO146, which is an effective anti-Chlamydia agent that targets the CtHtrA protein. CtHtrA is a lynchpin on the chlamydial cell surface due to its essential and multifunctional roles in the bacteria's stress response, replicative phase of development, virulence and outer-membrane protein assembly. This review summarizes the current understanding of CtHtrA function and presents a mechanistic model that highlights CtHtrA as an effective target for anti-Chlamydia drug development.
- Published
- 2017
- Full Text
- View/download PDF